5.8(top 2%)
Impact Factor
6.6(top 2%)
extended IF
177(top 1%)
citing journals
citing authors

Most Cited Articles of Alimentary Pharmacology and Therapeutics

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults20112K
Review article: the role of butyrate on colonic function20081.5K
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report2002862
The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress1997856
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis2005644
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis1997575
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis2009532
Increasing prevalence of coeliac disease over time2007515
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects2003504
Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission2020467
Review article: prebiotics in the gastrointestinal tract2006438
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging2005435
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease2006418
Colorectal cancer prevention in ulcerative colitis: a case-control study2000415
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis1999393
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease2011378
Review article: bifidobacteria as probiotic agents -- physiological effects and clinical benefits2005370
Chronic constipation: a survey of the patient perspective2007369
Review article: loss of response to anti-TNF treatments in Crohn's disease2011364
Review article: the global emergence of Helicobacter pylori antibiotic resistance2016355
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation2001354
Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease2003353
Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility2004350
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome2009348
Review article: short chain fatty acids in health and disease1998341